Advanced Nano-Formulations for Drug Delivery and Cancer Immunotherapy

Dear Colleagues,

The rapid evolution of nanotechnology has revolutionized drug delivery and immunotherapy, offering unprecedented precision in targeting cancer cells while minimizing systemic toxicity. This Special Issue explores advanced nano-formulations, including polymeric nanoparticles, lipid nanoparticles, nanofibers, hydrogels, nanocomposites, liposomes, and inorganic carriers engineered to enhance drug solubility, stability, and tumor-specific accumulation. A key focus is their role in cancer immunotherapy, where nano-formulations potentiate immune checkpoint inhibitors, cancer vaccines, and adoptive cell therapies by modulating the tumor microenvironment. Contributions highlight innovations in stimuli-responsive systems, combination therapies, and personalized nanomedicine, alongside challenges in scalability, biocompatibility, and clinical translation. By bridging interdisciplinary research, this Special Issue aims to accelerate the development of next-generation nanotherapeutics for improved oncological outcomes.

Dr. Narsimha Mamidi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.